Mackenzie Financial Corp Clearside Biomedical, Inc. Transaction History

Mackenzie Financial Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 24, 2023	SELL	$0.93 - $1.66 $4,275 - $7,631	-4,597 Reduced 13.82%	28,669 $29,000
Q4 2022 Feb 14, 2023	SELL	$1.0 - $1.5 $6,172 - $9,258	-6,172 Reduced 15.65%	33,266 $37,000
Q3 2022 Oct 07, 2022	BUY	$1.08 - $1.83 $6,469 - $10,961	5,990 Added 17.91%	39,438 $45,000
Q2 2022 Aug 10, 2022	BUY	$1.3 - $2.49 $28,198 - $54,010	21,691 Added 184.49%	33,448 $49,000
Q1 2022 May 13, 2022	BUY	$1.35 - $2.88 $15,871 - $33,860	11,757 New	11,757 $27,000

13.4M

17.6K

100

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $61.4M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Mackenzie Financial Corp with notifications on news.